aikuistyypin diabetes

name

• aikuistyypin diabetes

Works about aikuistyypin diabetes

• Aikuisiän diabeetikoiden hoidonohjauskurssien vaikuttavuus
• Aikuisten liikuntamotivaatioon vaikuttavat tekijät
• Aikuistyypin diabeteksen hoito pähkinänkuoressa
• Aikuistyypin diabeteksen hoito pähkinänkuoressa
• Aikuistyypin diabeteksen hoito-ongelmia
• Aikuistyypin diabeteksen hoitosuositus
• Aikuistyypin diabetes & liikunnan matkaopas
• Aikuistyypin diabetes : hoito-opas
• Aikuistyypin diabetes : metabolinen oireyhtymä
• Analytic review of quality of care of patients with type 2 diabetes mellitus
• Anthropometric measures of obesity : their association with type 2 diabetes and hypertension across ethnic groups
• Antioxidants, weight change and risk of type 2 diabetes
• Arginiini ja terveys
• Arginin och hälsa
• Assessment of risk and prevention of type 2 diabetes in primary health care
• Assessment of the metabolic syndrome in predicting incident type 2 diabetes in a Chinese population
• Association of zinc, omega-6 polyunsaturated fatty acids, delta-5 and delta-6 desaturase activities with the risk of type 2 diabetes and metabolic syndrome : a prospective population-based study
• Berry polyphenol absorption and the effect of northern berries on metabolism, ectopic fat accumulation, and associated diseases
• Candidate gene studies on body size, type 2 diabetes and related metabolic traits :
• Candidate genes for coronary heart disease in patients with type 2 diabetes : studies on the fatty acid-binding protein 2, [beta][sub 3]-adrenergic receptor, receptor for advanced glycation end products, apolipoprotein A1 and endothelial nitric oxide synthase genes
• Cardiometabolic health among male former elite athletes
• Cardiovascular autonomic function in coronary artery disease patients with and without type 2 diabetes : significance of physical activity and exercise capacity
• Cardiovascular risk factors and arterial function after gestational diabetes mellitus :
• Circulating fatty acids : associations with diet, genetic variations, low-grade inflammation and type 2 diabetes
• Clustering of cardiometabolic risk factors, liver enzymes and PNPLA3 polymorphism with special reference to children
• Coffee and risk of type 2 diabetes
• Dehkon 2D -hanke (D2D) 2003-2007
• Dehkon 2D -hanke 2003-2007 : kvalitatiivinen arviointi 2006
• Dehkon 2D -hanke Keski-Suomen sairaanhoitopiirin alueella 2003-2007
• Dehkon 2D-hanke (D2D) 2003-2007 : lisälehti vuonna 2004 julkaistuun projektisuunnitelmaan
• Depression and cognition in type 2 diabetes from a life course perspective
• Depression, poor sleep quality, and stress : associations with insulin resistance, insulin secretion and the metabolic syndrome in individuals without type 2 diabetes
• Determinants and predictive value of markers of glycemia and dyslipidemia for type 2 diabetes and cardiovascular disease
• Diabeetikon hoidonohjaus
• Diabeteksen ehkäisyn ja hoidon kehittämisohjelma (Dehko 2000-2010) : toinen väliarviointi
• Diabetes pääkaupunkiseudulla :
• Diabetic cardiomyopathy and post-infarct ventricular remodelling : effects of levosimendan in a rodent model of type II diabetes
• Dippii! : loppuraportti 2007
• Early detection of type 2 diabetes mellitus in Chinese and Indian adult population
• Early growth and adult disease : programming of coronary heart disease, Type 2 diabetes and hypertension by fetal and childhood growth
• Eastern Finnish saccular intracranial aneurysm disease : role of type 2 diabetes and hypertension temporal pattern of incidence
• Effects of insulin-lowering drugs in PCOS : endocrine, metabolic and inflammatory aspects
• Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone
• Effects of weight loss, rosiglitazone and metformin on liver fat content, insulin resistance and gene expression in adipose tissue
• Elintapaohjauksen lähtökohtia korkeassa diabetesriskissä olevilla henkilöillä tyypin 2 diabeteksen ehkäisyn toimeenpanohankkeessa (D2D) :
• Elämänlaadun ja elämäntapojen huomioonottaminen perusterveydenhuollossa
• Ennaltaehkäisyn kehittäminen Päijät-Hämeen terveydenhuollossa : interventiot osana Ikihyvä Päijät-Häme -tutkimus- ja kehittämishanketta
• Epidemiologic studies on diabetes, non-diabetic glycemic levels, insulin resistance and cardiovascular diseases
• Excess body weight, hyperandrogenism and polycystic ovary syndrome : impact on women’s reproductive and metabolic health
• Facets of negative affectivity, health behaviour, and risk factors of cardiovascular diseases
• Factors predicting mortality in type 2 diabetes : with special reference to physical exercise, blood pressure, proteinuria, inflammation and P wave duration
• Factors, complications and health-related quality of life associated with diabetes mellitus developed after midlife in men
• Fatty acids, fibre, carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk for type 2 diabetes : a cross-sectional analysis
• Gender, type 2 diabetes and risk of cardiovascular disease
• Genes regulating insulin secretion and insulin signaling as candidate genes for type 2 diabetes in subjects with impaired glucose tolerance
• Genetic and epidemiological studies on the role of adiponectin and PTP1B in the metabolic syndrome
• Genetic studies on type 2 diabetes mellitus with special emphasis on obesity and microvascular complications
• Genetic, epidemiological and cell culture studies on human resistin
• Genetics of sleep : sleep and comorbidities : connection at the genetic level
• Genomförande av Programmet för prevention av typ 2-diabetes : projektplan 2003-2007
• Ghrelin, metabolic risk factors and carotid artery atherosclerosis
• Glucose and lipid metabolism in human skeletal muscle
• Glucose metabolism in the diabetic and prediabetic state : implications for treatment and prevention of type 2 diabetes
• Glucose uptake in skeletal muscle and myocardium in insulin resistance : the effect of rosiglitazone treatment
• Glycemic index in epidemiologic study of type 2 diabetes
• Health economics and outcome studies on type 2 diabetes education and screening in a Chinese population
• Health-related quality of life and quality of care in middle-aged subjects with type 2 diabetes
• Heritability of type 2 diabetes and related traits
• Hoitoyhteistyön arviointi ja kehittäminen Jorvin sairaanhoitoalueella : esimerkkinä tyypin 2 diabetespotilaiden hoito
• Identification of biomarkers for type 2 diabetes
• Influence of exercise training on daily physical activity and risk factors for type 2 diabetes
• Insulin therapy in type 2 diabetes: initiation, impact on liver fat, role of combination therapy with glitazones or glinides
• Insulin treatment in type 2 diabetes
• Insulin-sensitizing genes and risk of type 2 diabetes : studies on the PGC-1α, PPARγ, adiponectin, leptin receptor and hepatic lipase genes
• Interrelationships of physical activity and depressive symptoms with cardiometabolic risk factors
• Job strain as a risk factor for obesity, physical inactivity and type 2 diabetes – a multi-cohort study
• Koettu terveys ihmisellä, jolla on pitkäaikainen terveysongelma : yli 65-vuotiaiden tyypin 2 diabeetikoiden terveyskokemus
• Kolesteroli, verenpaine, tyypin 2 diabetes
• Leisure-time physical activity, weight gain and health : a prospective follow-up in twins
• Links between insulin resistance, inflammation and subclinical macrovascular disease in type 2 diabetes
• Lisäystä terveysliikuntaan Pirkanmaan sairaanhoitopiirin alueella
• Liver fat in the metabolic syndrome and type 2 diabetes
• Liver insulin resistance and hyperglycemia : genetic determinants and association with cardiovascular risk factors
• Long-term effects of fenofibrate treatment on lipoproteins and surrogate markers of macrovascular and microvascular disease in people with type 2 diabetes
• Loppuraportti : diabeteksen ehkäisyn ja hoidon kehittämisohjelma Dehko 2000-2010
• Low-grade inflammation and markers of endothelial dysfunction in subjects with high risk of type 2 diabetes
• Metabolic and genetic abnormalities clustering with intra-abdominal obesity
• Metabolic syndrome : lifestyle intervention in subjects with impaired glucose tolerance
• Metabolinen oireyhtymä : miksi hoidan, miten hoidan
• Modeling cardiovascular complications of diabetes mellitus :
• Myocardial perfusion and glucose metabolism in patients with type 2 diabetes and coronary artery disease : special reference to the effects of insulin and rosiglitazone
• Nephrin in diabetes and in diabetes-related conditions : emphasis on urinary proteins immunoreactive with nephrin antibodies
• Nonalcoholic fatty liver disease in obesity and type 2 diabetes :
• Novel molecular regulators of adipose tissue metabolism
• Nutrition related factors and high-sensitivity C-reactive protein as predictors of coronary heart disease events in patients with type 2 diabetes
• Näkkyykö napa : tyypin 2 diabeteksen ehkäisyohjelman toimeenpanohankkeen toteutus ja tulokset Pohjois-Pohjanmaan sairaanhoitopiirissä 2003-2007
• Ohjaajien toiminta elintapamuutosten tukemisessa tyypin 2 diabeteksen ehkäisyn ryhmäohjauksessa
• Ohjauksen kirjaaminen : tyypin 2 diabetespotilaiden omahoito ja osaaminen potilasasiakirjoissa
• Opas kotihoidon ammattilaisille ja läheisille
• Palkitut ja arjessa koetellut : diabeteksen ehkäisyn ja hoidon hyvät käytännöt
• Pathophysiology and genetics of impaired insulin secretion and insulin resistance
• Patient reported outcomes in elderly patients with Diabetes Mellitus Type 2 in Slovenia
• Pharmacokinetic interactions of pioglitazone
• Phosphatidylinositol 3-kinase and type 2 diabetes : catalytic subunit p110[beta] as a candidate gene for type 2 diabetes and in vitro modelling of the insulin signalling pathway
• Physical activity, genetic variation, and type 2 diabetes
• Piilevät tulehdukset : miten tunnistat vaaralliset sairauksien aiheuttajat ja vältyt niiltä
• Plant foods in the prevention of type 2 diabetes mellitus with emphasis on dietary fiber and antioxidant vitamins
• Prevention among airline employees
• Prevention of type 2 diabetes with lifestyle intervention : emphasis on dietary composition and identification of high-risk individuals
• Programme for the Prevention of Type 2 Diabetes in Finland 2003-2010
• Quality and costs of diabetes care : comparison of two models in primary health care
• Quality and outcome indicators for prevention of type 2 diabetes in Europe : IMAGE
• Raportti Pirkanmaan sairaanhoitopiirin ja TedBM-hankkeen yhteistyöstä 2007-2009
• Regulation of alternative splicing in obesity and weight loss
• Rekommendationer för vård och behandling vid typ 2 diabetes
• Role of body iron stores in glucose homeostasis and type 2 diabetes
• Ryhmäohjaus diabeteksessa ongelmalähtöisen oppimisen menetelmällä : tyypin 1 diabetes
• Serum uric acid and metabolic risk factors in three ethnic groups: Asian Indians and Creoles in Mauritius and Chinese in Qingdao, China
• Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor genes and insulin sensitivity
• Socioeconomic differences in the development and prevention of type 2 diabetes :
• Spectroscopy of tissue triglyceride composition : in vitro and in vivo studies
• Starting insulin treatment in type 2 diabetes
• Studies by positron emission tomography
• Studies on selected human obesity candidate genes : genetic variation and adipose tissue expression
• Suunnitelma Tyypin 2 diabeteksen ehkäisyohjelman toteuttamiseksi : projektisuunnitelma 2003-2007
• Tartu toimeen : ehkäise diabetes
• The effects of physical activity and diet change on intracellular lipids and metabolism in mice with diet-induced obesity
• The epidemiology of macrovascular complications of diabetes in Finland 1992-2002
• The grey zone between type 1 and type 2 diabetes : genetic aspects of diabetes in adults
• The healthy Nordic diet, obesity and obesity-related metabolic risk factors
• The role of ghrelin in obesity and insulin resistance
• The role of low birth weight and resistin in metabolic syndrome
• Transcription factors as candidate genes for type 2 diabetes : studies on peroxisome proliferator-activated receptors, hepatic nuclear factor 4α and PPARγ coactivator 1α
• Tutkien terveyttä 2005
• Typ 2 -diabetes : vägledning för dig med vuxendiabetes
• Typ 2-diabetes : vägledning för dig med vuxendiabetes
• Typ II -diabetes : en vägledning
• Type 1 and type 2 diabetes among young adults in Finland : incidence and perinatal exposures
• Type I family history and gad autoantibodies in subjects without diabetes and patients with type 2 diabetes : prevalence and association with insulin deficiency and development of diabetes
• Tyypin 2 diabeetikoiden hoitoketjut ja hoidonresurssit Jyväskylän kaupungin terveyspalveluissa
• Tyypin 2 diabeetikoiden ryhmäohjausmalli terveydenhuollon käyttöön : pilottiraportti : mallin toteutettavuus ja hyväksyttävyys
• Tyypin 2 diabeteksen ehkäisyohjelma 2003-2010
• Tyypin 2 diabeteksen ehkäisyohjelma : väestöstrategia 2003-2010
• Tyypin 2 diabeteksen ehkäisyohjelma Tampereella
• Tyypin 2 diabeteksen ennaltaehkäisyn toimeenpanohanke 2003-2007
• Tyypin 2 diabeteksen riskiryhmään kuuluvien työikäisten henkilöiden painonhallinnan ja elintapamuutoksen tunnuspiirteitä
• Tyypin 2 diabeteksen riskitekijät ja poikkeavan glukoosiaineenvaihdunnan seulonta perusterveydenhuollossa
• Tyypin 2 diabetes
• Valtimoterveydeksi! : terveyden edistämisen käsikirja
• Variation in the properties of low density lipoproteins : impact of serum triglycerides
• Vascular and platelet function in insulin resistance
• Verensokeri kuriin 8 viikossa : nopeita ratkaisuja diabetekseen ja ylipainoon
• Verensokeri kuriin kahdeksassa viikossa
• Voimaantumiseen pohjautuva tyypin 2 diabeteksen omahoidon tuki apteekissa : esimerkkinä Mäntyharjun Havu-apteekki
• Vuxendiabetes & motion